Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes
- PMID: 20574506
- PMCID: PMC2886411
Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes
Conflict of interest statement
The faculty reported the following financial relationships or relation-ships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following planners and managers, Linda Graham, RN, BSN, BA, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Figures
References
-
- Kornbluth A, Sachar B. Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371–1385. - PubMed
-
- Farmer RG, Easley KA, Rankin GB. Dig Dis Sci. 1993;38:1137–1146. - PubMed
-
- Safdi M, DeMicco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 1997;92:1867–1871. - PubMed
-
- Lichtenstein GR, Kamm MA, Sandborn WJ, et al. MMX mesalazine for the induction of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Aliment Pharmacol Ther. 2008;1:1094–1102. - PubMed
LinkOut - more resources
Full Text Sources